Dnajc12 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
DnaJ Heat Shock Protein Family (Hsp40) Member C12 is encoded by the DNAJC12 gene located on chromosome 10q22.1. This gene encodes a member of the DNAJ/Hsp40 family of molecular co-chaperones, which assist Hsp70 family proteins in protein folding, refolding, and degradation processes. DNAJC12 is expressed predominantly in the brain and plays critical roles in neuronal protein homeostasis, ER-associated degradation (ERAD), and cellular stress responses. Mutations in DNAJC12 have been implicated in hyperphenylalaninemia and neurodevelopmental disorders, while dysregulated expression is observed in various neurodegenerative diseases. [1]
| Gene Symbol | DNAJC12 |
|---|---|
| Full Name | DnaJ Heat Shock Protein Family (Hsp40) Member C12 |
| Chromosome | 10q22.1 |
| NCBI Gene ID | 56521 |
| OMIM | 618136 |
| Ensembl ID | ENSG00000156026 |
| UniProt ID | Q9Y3X4 |
| Protein Length | 305 amino acids |
| Molecular Weight | 34.2 kDa |
DNAJC12 contains several functional domains essential for its chaperone activity:
The J domain contains the conserved HPD motif (His-Pro-Asp) critical for interaction with Hsp70 family members. The C-terminal domain contains a stretch of acidic residues that may assist in client protein recognition.
DNAJC12 functions as a co-chaperone through the following mechanisms:
DNAJC12 exhibits tissue-specific expression:
DNAJC12 is associated with several diseases:
| Disease | Mechanism | Evidence |
|---|---|---|
| Hyperphenylalaninemia | Biallelic mutations cause phenylalanine metabolism defects | OMIM 618136 |
| Neurodevelopmental disorders | Loss-of-function mutations affect neuronal protein homeostasis | Case reports |
| Alzheimer's Disease | Downregulated in AD brain; impaired protein quality control | Transcriptomic studies |
| Parkinson's Disease | Potential role in ER stress and protein aggregation | Animal models |
| Amyotrophic Lateral Sclerosis | Dysregulated expression in motor neurons | Postmortem studies |
In neurodegenerative diseases, DNAJC12 dysfunction contributes to:
Targeting DNAJC12 for therapeutic benefit:
Mouse models with DNAJC12 knockout show:
The study of Dnajc12 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.